News Releases

Vyaire Medical Appoints Medical Device Veteran, Gaurav Agarwal, as Chief Executive Officer

January 21, 2020

CHICAGO – January 21, 2020 ― Vyaire Medical, Inc. today announced that its Board of Directors has appointed Gaurav Agarwal as Chief Executive Officer, effective immediately. Agarwal succeeds Dave Eckley, who is stepping down as Chief Executive Officer, but will remain on the company’s Board of Directors. Vyaire Medical is the largest company in the global healthcare ecosystem fully dedicated to respiratory care.  With a vision of enabling, improving and extending the lives of patients, the company is committed to innovating and delivering the best respiratory solutions to healthcare customers around the world. Agarwal brings to Vyaire Medical extensive global leadership experience in medical devices and a proven track record in driving innovation, improving patient outcomes, and creating exceptional value for customers.  Most recently, as President and Chief Operating Officer of KCI, an Acelity Company, Agarwal transformed the company into an undisputed leader in advanced wound care, by finding ground-breaking healing solutions for current and new customer segments.  Prior to that, he served as President, Orthopaedic Reconstruction at Smith & Nephew, where he was responsible for defining a cutting-edge global strategy that expedited product development and redefined the company’s portfolio for joint reconstruction.  Before that, he held Vice President and General Manager positions at GE Healthcare. “We are thrilled to welcome Gaurav to Vyaire,” said Steven Dyson, Chairman of Vyaire Medical’s Board of Directors.  “He brings a wealth of experience in driving innovation and growing businesses in the medical device industry.  In the five years that I’ve known him, I’ve seen first-hand the positive impact of his focus on the customer, his attention to employees, and his ability to create value for shareholders.  He is the perfect fit for Vyaire at this time.” “I’m excited to be joining Vyaire Medical. It has a clear vision and mission, a strong team in place, and a robust pipeline of products to meet the needs of our patients and customers,” said Agarwal. “With a formidable footprint, and the ability to leverage technology to create best-in-class solutions, my focus will be working with the team to push the boundaries on innovation, create additional value for customers and patients and secure Vyaire’s position as the leader in respiratory care.”      In 2019, the company launched several new products.  Most notably, the bellavista™ 1000e was introduced in the US, a uniquely versatile ventilator system that allows one device to work across a broad range of patients and situations – enhancing workflow, simplifying training, and improving patient outcomes.  Two of the latest Pulmonary Function Testing (PFT) technologies were also introduced in the US:  Vyntus™ BODY and Vyntus™ ONE, both with SentrySuite™ software.  Internationally, SuperNO2VA™, the exclusive nasal ventilation mask was brought to market. Dyson added, “Dave Eckley has been an invaluable leader for Vyaire Medical this past year, defining a clear vision and mission, championing a customer-first culture, and establishing a seamless supply chain operation across legacy systems.  The board extends its deep appreciation and thanks on behalf of our employees, partners, and customers for Dave stepping into the CEO role during this critical time.” “Vyaire Medical is a special company, and leading the team has been an honor,” Eckley said.  “I’m proud of what we accomplished together.  Vyaire is poised to be the global leader in respiratory care, and I am confident with Gaurav’s leadership the company will not only reach new heights, but it will have an incredibly powerful impact on the lives of customers and patients.” About Vyaire Medical Headquartered near Chicago, IL., Vyaire Medical - a global company dedicated to respiratory care — enables, improves and extends lives with an unyielding focus on improving patient outcomes and increasing value for customers. The company was formed in October 2016 to serve healthcare providers with innovative devices and service solutions across the respiratory and anesthesia continua of care. Vyaire’s legacy brands have a 65-year track record of pioneering and advancing respiratory diagnostics, ventilation, and anesthesia delivery & monitoring. From original brands including Bird, Bear, and JAEGER to industry leaders AirLife™, Vital Signs™, Viasys, and many others — Vyaire Medical is recognized, trusted and preferred by specialists in respiratory and anesthesiology healthcare worldwide. Learn more at www.vyaire.com. Contact Catherine Riedel Vyaire Communications Phone:  +1 (312) 209 0250 Email: Catherine.Riedel@vyaire.com

Compatible, Reusable MX40™ Telemetry Adapter Now Available

January 15, 2020

New Adapter Supports Increased Inpatient Mobility CHICAGO, January 15, 2020—Vyaire Medical has announced the U.S. availability of its MX40™ adapter, a reusable telemetry adapter that is compatible with Philips Intellivue MX40 wearable patient monitor. The small, lightweight adapter allows patients to move freely throughout the hospital while they are receiving electrocardiogram (ECG) monitoring. Designed for use with both 5 and 6 leadwire sets, the new adapter can be used in conjunction with the Philips Intellivue MX40 wearable patient monitor. It features a SpO2 port with a securing mechanism that can be used while the patient is walking around with the device. It also has a closure cap that covers the port while it’s not in use. The SpO2 port is compatible with the Masimo LNCS pulse oximeter as well as the Philips 9 pin pulse oximeter sensors. The MX40 adapter also utilizes the Vyaire Multi-Link™ X2 solutions allowing standardization of single patient use leadwires across multiple monitoring platforms, including: Philips, GE, Mindray, Nihon Kohden and Spacelabs. “The MX40 adapter is another example of Vyaire’s ability to increase patient mobility and clinician workflow while providing a decreased risk of infection,” said Jeff Zanni, vice president of U.S. Sales. “It also allows our company to partner with both customers and other innovators to implement solutions that are patient-centric.” Infection prevention is a key metric in healthcare systems. Using Vyaire’s single patient-use leadwire can help eliminate the risk of cross-contamination often seen with reusable leadwires. About Vyaire Medical Headquartered near Chicago, IL., Vyaire Medical - a global company dedicated to respiratory care — enables, improves and extends lives with an unyielding focus on improving patient outcomes and increasing value for customers. The company was formed in October 2016 to serve healthcare providers with innovative devices and service solutions across the respiratory and anesthesia continua of care. Vyaire’s legacy brands have a 65-year track record of pioneering and advancing respiratory diagnostics, ventilation, and anesthesia delivery & monitoring. From original brands including Bird, Bear, and JAEGER to industry leaders AirLife™, Vital Signs™, Viasys, and many others — Vyaire Medical is recognized, trusted and preferred by specialists in respiratory and anesthesiology healthcare worldwide. Learn more at www.vyaire.com.  

Vyaire Medical Enters Exclusive, Five-Year Agreement to Distribute Fenom Pro® Asthma Monitor in Multiple Countries

January 8, 2020

CHICAGO and PLEASANTON, Calif. – January 8, 2020 ― Vyaire Medical, Inc. and Spirosure, Inc. have entered a five-year agreement for Vyaire to exclusively distribute Spirosure’s Fenom Pro® Asthma monitor in the United States, Germany, the Netherlands and the United Kingdom.    Spirosure’s Fenom Pro is one of two FDA-cleared devices that measures FeNO, the most established biomarker for diagnosing and managing asthma. FeNO—Fractional exhaled Nitric Oxide- is exhaled in a patient’s breath.  “Offering Fenom Pro is another example of Vyaire offering healthcare providers best-in-class, easy-to-use diagnostic, management and treatment tools for respiratory conditions in any healthcare setting,” said Lisa Rose, chief innovation officer. “This tool broadens our diagnostics portfolio options and increases the options clinicians have to give the best patient care available.” Fenom Pro offers the fastest test time among similar devices available in the U.S. and requires the least amount of maintenance among similar devices. The measurements obtained from Fenom Pro can assist in evaluating treatment response for certain conditions, such as asthma. Data from Fenom Pro will also integrate with Vyaire’s SentrySuite™ software platform, offering healthcare providers more context and information about each patient’s unique respiratory condition.  “Partnering with Vyaire will enable Spirosure to offer easy and reliable FeNO measurement to top respiratory labs in the US and Europe,” said Vivek Balasubramanyam, VP of Sales and Marketing. “This is a tremendous opportunity for us, and for all asthma patients to gain access to routine FeNO monitoring as part of their care.”  About FeNO Nitric Oxide (NO) is produced in the lungs and becomes more concentrated when the lungs are inflamed due to allergic asthma. FeNO is a standardized measure of this concentration and provides a quick and non-invasive biomarker for airway inflammation. Measurement of FeNO helps assess the need for anti-inflammatory medication and supports ongoing monitoring of anti-inflammatory therapy for conditions like asthma. Routine FeNO testing can help allergists, pulmonologists and respiratory therapists determine the best treatment path, and avoid potentially unnecessary medicines.  About SPIROSURE Spirosure Inc. was founded in 2011 in Pleasanton, California by Dr. Solomon Ssenyange and Ryan Leard. It is focused on improving quality of life for the 300 million people around the world who have asthma by offering tools that enable proactive intervention. In recent years, non-invasive measurement and monitoring of the fraction of exhaled nitric oxide (FeNO) in exhaled breath has become established as the biomarker of asthma. Learn more at spirosure.com and fenomasthma.com. About Vyaire Medical  Headquartered near Chicago, IL., Vyaire Medical - a global company dedicated to respiratory care — enables, improves and extends lives with an unyielding focus on improving patient outcomes and increasing value for customers. The company was formed in October 2016 to serve healthcare providers with innovative devices and service solutions across the respiratory and anesthesia continua of care.  Vyaire’s legacy brands have a 65-year track record of pioneering and advancing respiratory diagnostics, ventilation, and anesthesia delivery & monitoring.  From original brands including Bird, Bear, and JAEGER to industry leaders AirLife™, Vital Signs™, Viasys, and many others — Vyaire Medical is recognized, trusted and preferred by specialists in respiratory and anesthesiology healthcare worldwide. Learn more at www.vyaire.com.

Smaller, Reusable ApexPro FH Telemetry Adapter Now Available

October 3, 2019

CHICAGO - October 3, 2019 - Vyaire Medical has announced the U.S. availability of its smaller, reusable ApexPro FH telemetry adapter for use with the GE ApexPro FH System.  Designed with input from clinicians, the new version of the adapter connects to the GE ApexPro FH telemetry system. The smaller design offers a more secure connection making it easier for patients to move about the hospital while receiving ECG monitoring. The adapter can be used in conjunction with Vyaire's Multi-Link™ X2 ECG portfolio. "The new ApexPro FH adapter demonstrates our commitment to putting customers and patients first.  The smaller size improves patient comfort and mobility.  The compatibility with our disposable leadwires reduces cross-contamination exposure, because the leadwires can stay with the patient throughout the hospital.  Both lead to improved patient outcomes, which is a win for everyone." Joel Brandon, VP Marketing, Vyaire Medical. The ApexPro FH uses one of our Multi-Link X2 solutions that allows for standardization of single patient use leadwires across multiple monitoring platforms including: GE, Philips, Mindray, Nihon Kohden and Spacelabs. Additionally, the new adapter helps optimize patient flow through the hospital allowing patients increased mobility.  Infection prevention is a key metric in healthcare systems. By using our single patient use leadwires it can help eliminate the risk of cross contamination often seen with reusable leadwires.  About Vyaire Medical  Vyaire Medical is the healthcare industry's dedicated breathing company. The company was formed in October 2016, bringing together, legacy brands with a 65-year track record of pioneering, innovating, and advancing respiratory and anesthesia continua of care. Industry leading brands include Bird, Bear, Jaeger, Vyntus, AirLife™, Vital Signs™, bellavista, fabian, SuperNO2VA, and many others. Vyaire Medical has over 27,000 distinct products recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide.  All designed to enable, improve and extend patient lives through the care of healthcare professionals.    

Vyaire Medical Announces Global Market Recall of enFlow™ Fluid Warming System Disposable Cartridges

March 13, 2019

CHICAGO - March 13, 2019- Vyaire Medical today announced an immediate global recall of the enFlow™ disposable cartridges used with the enFlow™ fluid warming system (part numbers 980200EU, 980202EU). Vyaire is directing customers to suspend use of the enFlow™ system and follow instructions provided by the Company in its recall notice with regard to the affected cartridges. This recall does not affect the separate enFlow™ Warmer, Controller, and accessories. Customers are encouraged to retain these items as Vyaire is exploring the development of a new cartridge, compatible with the current enFlow™ system, to minimize aluminum exposure.   This decision is based on recently conducted internal testing which indicated that there is the potential to elute aluminum from the enFlow™ disposable cartridge during intravenous warming therapy with fluid and blood solutions. This action was not prompted by adverse incidents or product complaints.  At Vyaire, we put patient safety above all else, and believe that this recall is in the best interests of both our customers and their patients.While we are immediately recalling the affected cartridges from the market now, we intend to actively work with our regulators to explore design or labeling changes that would support the reintroduction of enFlow™ disposable cartridges in the future.  Vyaire's recall of enFlow™ cartridges is consistent with its commitment to ensuring the highest quality standards for its products and the safety of patients worldwide.  About Vyaire Medical  Headquartered in Chicago, IL., Vyaire Medical supports and improves the lives of patients with a focus on improving patient outcomes and increasing value for customers. The company was formed in October 2016, to serve healthcare customers with innovative device and service solutions across the respiratory and anesthesia continua of care. Vyaire's legacy brands have a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, ventilation, and anesthesia delivery & patient monitoring.  From industry-pioneering brands that include Bird, Bear, and Jaeger to respected industry leaders AirLife™, Vital Signs™, Viasys, and many others - Vyaire Medical has nearly 27,000 distinct part numbers recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide.    Learn more at www.vyaire.com.

Vyaire Medical executes on its plan to become a global leader in respiratory care

April 26, 2018

CHICAGO & LONDON -  April 26, 2018 – Vyaire Medical (the “Company”), a global leader in respiratory care, today announced that it has acquired Acutronic Medical Systems and, separately, entered into a definitive agreement to acquire imtmedical. Acutronic, a Switzerland and Germany-based leader in the design and manufacture of neonatal ventilation equipment, is globally recognized for its innovative ventilation solutions designed for both neonatal and pediatric intensive care units. imtmedical, based in Switzerland, is a developer, manufacturer and distributor of acute care mechanical ventilation products utilized in acute care centers, long-term care facilities, home healthcare as well as the emergency services and transport markets. The imtmedical transaction, which is subject to customary regulatory and other approvals, is expected to close in the second quarter. The Acutronic and imtmedical acquisitions immediately enhance Vyaire Medical’s product offering, complementing investments made by the Company through internal development programs. In combination, these investments have allowed Vyaire Medical to completely renew its ventilation portfolio within the past 18 months. “The transactions we are announcing today, along with our own internal development efforts, underscore our commitment to positioning Vyaire Medical as a global respiratory care leader. Our acquisition of Acutronic and imtmedical immediately enhance our product portfolio, expand intellectual capital and broaden our technological capabilities; all of which will accelerate Vyaire Medical’s growth. We could not be more excited about taking these amazing products, in combination with our own, to market to advance our mission of improving patient outcomes and providing increased value to our customers.” Dave Mowry, Vyaire Medical’s President and Chief Executive Officer Vyaire Medical also announced today that funds advised by Apax Partners (the “Apax Funds”) have completed their purchase of Becton, Dickinson & Company’s remaining stake in the Company. Vyaire Medical is now an independent, standalone company owned by the Apax Funds.   Steven Dyson and Arthur Brothag, Partners at Apax Partners, said, “These new acquisitions are exciting steps forward for Vyaire Medical and build on the strong progress made by the Company’s management over the past year and a half. We join Dave Mowry in welcoming both the Acutronic and imtmedical teams to the Vyaire family and are excited about our joint future. We look forward to our ongoing work with Vyaire Medical as it continues to grow as the leader in respiratory care.” About Vyaire Medical  Vyaire Medical supports and improves the lives of patients with a laser-focus on improving patient outcomes and increasing value for customers. The Chicago, IL-headquartered company was formed in October 2016 to serve healthcare customers with innovative device and service solutions across the respiratory and anesthesia continua of care. Vyaire's brands have a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, ventilation, and anesthesia delivery & patient monitoring. From industry-pioneering brands that include Bird, Bear, and JAEGER to respected industry leaders AirLife®, Vital Signs®, Viasys, and many others – Vyaire Medical has nearly 27,000 distinct part numbers recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide. Learn more at www.Vyaire.com. About Apax Partners   Apax Partners is a leading global private equity advisory firm. Over its more than 35-year history, Apax Partners has raised and advised funds with aggregate commitments of over $50 billion. The Apax Funds invest in companies across four global sectors of Healthcare, Tech & Telco, Services and Consumer. These funds provide long-term equity financing to build and strengthen world-class companies. Apax Partners has a strong track record in corporate carve-outs, supported by its Operational Excellence Practice, a team of dedicated operating specialists who support deal teams and drive value creation in the portfolio. For more information see: www.apax.com. About Acutronic Medical Systems   Acutronic is a Switzerland and Germany-based global leader in the area of neonatal ventilation equipment, offering innovative solutions for the Neonatal Intensive Care Unit (NICU) and Pediatric Intensive Care Unit (PICU). Over the course of its long history, Acutronic has established itself as a pioneer within the neonatal monitoring and ventilation segment of the respiratory markets. Acutronic’s products and solutions consistently earn high praise and accolades from customers and are well-respected across the broader markets by key opinion leaders around the globe. Learn more at: www.acutronic-medical.ch. About imtmedical  imtmedical is known for its world class developments in medical ventilator and testing devices and its internationally renowned medical ventilation experts. imtmedical brings continuous efforts to improve and protect its substantial R&D activities, its innovative solutions, and thereby supporting its leading position in the marketplace as an innovative company providing highest quality and leading medical ventilators to its customers. Learn more at: www.imtmedical.com.   Media Contacts   For Vyaire Medical: David Stafford | +1 872-757-0300 | david.stafford@vyaire.com For Apax Partners: Global Media: Andrew Kenny, Apax | +44 20 7 872 6371 | andrew.kenny@apax.com  USA Media: Todd Fogarty / Aduke Thelwell, Kekst | +1 212-521 4800 | Apax@kekst.com  UK Media: Matthew Goodman / James Madsen, Greenbrook | +44 20 7952 2000 | apax@greenbrookpr.com  

Vyaire Marks 1st Anniversary With AARC 2017 Zenith Award for Respiratory Product Excellence

October 4, 2017

INDIANAPOLIS – October 4, 2017 ― Vyaire Medical, Inc., the world’s largest pure-play “breathing company,” has marked its first anniversary as a standalone company by accepting the American Association of Respiratory Care’s 2017 Zenith Award at the 63rd International Respiratory Congress and Exhibition being held October 4-7, 2017 in Indianapolis. The 2017 award marks the tenth time Vyaire and its predecessor companies have received this distinguished award. Voted on by AARC members, the Zenith Award is given to the top companies in the respiratory care industry and is widely considered the “people’s choice” award for the respiratory care profession. AARC members are asked to evaluate and identify outstanding companies using criteria including: quality of equipment and supplies; accessibility and helpfulness of sales personnel; overall company responsiveness; service records; truth in advertising; and support of the respiratory care profession. “We have had a very busy 2017 realigning every aspect of our business to better serve our customers, add value to our partnerships and lay the groundwork to more actively lead our industry,” said Dave Mowry, President and Chief Executive Officer  Vyaire is highlighting its ventilation, respiratory diagnostics and airway management solutions, including AirLife®, Vyntus®, AVEA® and 3100A HFOV product brands, in booth 313 at the AARC Congress. “We’ve spent a lot of time in this first year re-engineering our organization, operations and culture to keep the customer at the center of everything we do. Maintaining our position as a Zenith Award recipient validates the dedication and hard work of Vyaire employees around the world.” Vyaire was formed as a standalone, global respiratory solutions company on October 3, 2016 when BD divested its CareFusion Respiratory Solutions assets, including its respiratory diagnostics, mechanical ventilation, respiratory care consumables and anesthesia delivery & patient monitoring product lines. About Vyaire Medical  Headquartered in Chicago, IL, Vyaire Medical supports and improves the lives of patients with a laser-focus on improving patient outcomes and increasing value for customers. The company was formed in October 2016, to serve healthcare customers with innovative device and service solutions across the respiratory and anesthesia continua of care. Vyaire’s legacy brands have a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, mechanical ventilation, respiratory care consumables, and anesthesia delivery & patient monitoring. From industry-pioneering brands that include Bird, Bear, and JAEGER to respected industry leaders AirLife®, Vital Signs®, Viasys, and many others — Vyaire Medical has nearly 27,000 distinct products recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide. Learn more at www.Vyaire.com. Contact: David Stafford, CFO Vyaire Medical, Inc. (224) 706-6600 david.stafford@vyaire.com

Vyaire Marks Industry Arrival by Earning AARCs Zenith Award for Respiratory Product Excellence

October 17, 2016

SAN ANTONIO - October 17, 2016 - Vyaire Medical, Inc., the world's largest pure-play "breathing company," was presented with the Zenith Award by the American Association for Respiratory Care (AARC) at the 62nd International Respiratory Congress and Exhibition being held October 15, 2016 through October 18, 2016 in San Antonio, Texas. Vyaire was formed as a standalone, global respiratory solutions company on October 3, 2016 when BD divested its Respiratory Solutions assets, including its Anesthesia Delivery and Patient Monitoring, Respiratory Diagnostics, Mechanical Ventilation, and Respiratory Care Consumables lines.   Voted on by AARC members, the Zenith Award is given to the top companies in the respiratory care industry and is widely considered the "people's choice" award for the respiratory care profession. AARC members are asked to evaluate and identify outstanding companies using criteria including: quality of equipment and supplies; accessibility and helpfulness of sales personnel; overall company responsiveness; service records; truth in advertising; and support of the respiratory care profession. This year's award marks the ninth time Vyaire and its predecessor companies have received this distinguished award. "We are proud to accept the AARC's 2016 Zenith Award as a new name in this industry with roots that extend back to the beginning in 1955, when Dr. Forrest Bird developed the first mechanical ventilator," said Ruth Lundstrom, Vice President and General Manager of Ventilation at Vyaire. While our company name has changed, the people from across all of our business segments are the same. It is these talented people who have worked so hard to serve this profession that enabled us to receive this award. Vyaire CEO Dave Mowry was also present at the conference, meeting with customers and learning from their perspective on the current and anticipated challenges they face in providing quality and cost-effective care to their patients. "Our focus is squarely on our current markets, the respiratory solutions space, as we will build our new brand on the foundation of great products and amazing people that define Vyaire," CEO Dave Mowry Most importantly, we will continue to partner with healthcare professionals to deliver meaningful innovation across the products, services and support that directly contribute to improved outcomes for patients. Vyaire is highlighting its respiratory solutions in booth 1012 at the AARC Congress including ventilators, respiratory diagnostics equipment and AirLife® respiratory products. About Vyaire Medical Vyaire Medical is the world's largest pure-play "breathing company," supporting and improving the lives of patients with a laser-focus on improving patient outcomes and increasing value for customers. The company was formed in October 2016 as an $800 million "startup" with a 65-year track record of pioneering, innovating, and advancing respiratory diagnostics, ventilation, and anesthesia delivery & patient monitoring. From industry-pioneering brands like Bird, Bear, and JAEGER to respected industry leaders like AirLife,® Vital Signs,® Viasys, and many others - Vyaire Medical has nearly 20,000 distinct part numbers recognized, trusted and preferred by specialists in the respiratory therapy and anesthesiology healthcare markets worldwide. Vyaire Medical has more than 5,000 employees around the world, all focused on a shared purpose of closely collaborating with healthcare providers and institutions to deliver world-class products, support, and services that contribute to the overall health and wellness of society. Learn more at www.Vyaire.com.  Contact: Larry Marchese LEGIONTHIRTEEN (617)733-8899 lmarchese@legionthirteen.com

3 of 4